The Ph.D. Program for Neural Regenerative Medicine

Medicine & Life Sciences

1. Accidental Falls 11%
2. Alzheimer Disease 12%
3. andrographolide 9%
4. Antioxidants 10%
5. Antrodia 7%
6. Apoptosis 24%
7. Arsenic 34%
8. beta-thujaplicin 7%
9. Biomarkers 8%
10. Blood Platelets 33%
11. Brain 14%
12. Brain Injuries 9%
13. Brain Ischemia 7%
14. Breast Neoplasms 15%
15. Calcium 7%
16. Carcinogenesis 7%
17. CCAAT-Enhancer-Binding Protein-delta 11%
18. Cell Death 8%
19. Cell Movement 12%
20. Cell Proliferation 10%
21. Cognition 7%
22. Cognitive Dysfunction 9%
23. Cohort Studies 22%
24. Collagen 12%
25. Colonic Neoplasms 9%
26. Colorectal Neoplasms 9%
27. Confidence Intervals 17%
28. Craniocerebral Trauma 7%
29. Cyclooxygenase 2 13%
30. Databases 8%
31. Dementia 13%
32. Down-Regulation 8%
33. Elderly 7%
34. Electric Stimulation 10%
35. Endothelial Cells 9%
36. Epithelial Cells 6%
37. Gene Expression 9%
38. Genes 20%
39. Genetic Polymorphisms 9%
40. Glioblastoma 23%
41. Glioma 15%
42. Growth 9%
43. Heme Oxygenase-1 7%
44. Hepatocellular Carcinoma 9%
45. In Vitro Techniques 12%
46. Incidence 8%
47. Infarction 6%
48. Inflammation 8%
49. Lipopolysaccharides 11%
50. lipoteichoic acid 6%
51. Lung Neoplasms 11%
52. Messenger RNA 8%
53. Methylation 7%
54. MicroRNAs 7%
55. Middle Cerebral Artery Infarction 9%
56. Mitogen-Activated Protein Kinases 6%
57. Mortality 9%
58. Motorcycles 9%
59. Mucocutaneous Lymph Node Syndrome 14%
60. National Health Programs 9%
61. Neoplasm Metastasis 10%
62. Neoplasms 27%
63. Neuroprotective Agents 8%
64. Nicotine 9%
65. Nicotinic Receptors 8%
66. Nitric Oxide Synthase Type II 8%
67. Odds Ratio 12%
68. Oxidative Stress 8%
69. p38 Mitogen-Activated Protein Kinases 13%
70. Parkinson Disease 17%
71. Pharmaceutical Preparations 7%
72. Phosphorylation 18%
73. Platelet Activation 25%
74. Platelet Aggregation 20%
75. Population 21%
76. Protein Kinase C 11%
77. Proteins 17%
78. pterostilbene 7%
79. Quality of Life 8%
80. Radiosurgery 8%
81. Reactive Oxygen Species 9%
82. Rehabilitation 7%
83. Single Nucleotide Polymorphism 8%
84. Sleep 9%
85. Smooth Muscle Myocytes 7%
86. Spinal Cord Injuries 12%
87. Stroke 55%
88. Survival 7%
89. Taiwan 100%
90. Temozolomide 13%
91. Therapeutics 19%
92. Thrombin 7%
93. Thrombosis 9%
94. Tissue Plasminogen Activator 7%
95. Traumatic Brain Injury 31%
96. triflavin 13%
97. Up-Regulation 9%
98. Urinary Bladder 8%
99. Wounds and Injuries 19%